Recorded device evidence

SPECULUM, VAGINAL, NONMETAL (K120743): indications, design and recorded evidence

The acquired K120743 file contains product-specific indications and users, recorded comparison and differences, non-clinical evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 0 selected decisions under primary code HIB. 0 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

No quartiles are displayed: this complete-year cohort has fewer than 20 valid pairs.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K120743 ↗ · this pageSPECULUM, VAGINAL, NONMETAL2012-03-12 → 2012-03-2311Special
K252208 ↗JFord Speculum Sleeve™2025-07-15 → 2026-03-06234Traditional
K133857 ↗BRELLA-SPEC(TM) VAGINAL SPECULUM2013-12-19 → 2014-04-28130Traditional
K132668 ↗IOB DISPOSABLE SPECULUM2013-08-27 → 2014-01-17143Traditional
K130046 ↗CLEARSPEC SINGLE USE VAGINAL SPECULUM2013-01-08 → 2013-08-06210Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K120743 · PDF page 1 ↗ Source 2

KleenSpec® Single     Use       Vaginal           Speculum

The       disposable         vaginal         speculumn            is      used           to      dilate        the     vagina           and     expose          the    interior          of
the         vagina       and       exterior      of the        cervix        during     pelvic           examinations            and      other      gynecological
procedures.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Recorded comparison and differences

K120743 · PDF page 2 ↗ Source 3

The       subject      device        has       the      same          technological          characteristics              and          indications           for      use     as
the    predicate      KleenSpec® Single          Use     Vaginal            Speculum.      The     addition        of the       extra      small
size      vaginal          speculum       does         not        introduce         any     new        concerns             regarding         safety       or         efficacy.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

Non-clinical evidence actually described

K120743 · PDF page 2 ↗ Source 3

Verification         and      validation         tests       were       conducted            in    accordance             with       Welch        Allyn          design
control       procedure.                      They       are         tested        using       established       testing       procedures          to         ensure       the
products       performance           parameters              conform        to    the         product      design         specifications.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Treat these as documented evidence themes in this case, including any limitations or negative statements. Ask which protocols, design inputs and acceptance rationale would be justified for your product; these excerpts are not a mandatory test panel.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK120743 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categorySPECULUM, VAGINAL, NONMETAL [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantWelch Allyn, Inc. [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeHIB [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2012-03-23 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeSpecial [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2012-03-12 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Recorded comparison and differences — what differs in our product?

    The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

    Useful evidence: Feature-by-feature differences and the underlying cited documents; no automated predicate selection.

  3. Non-clinical evidence actually described — what differs in our product?

    Treat these as documented evidence themes in this case, including any limitations or negative statements. Ask which protocols, design inputs and acceptance rationale would be justified for your product; these excerpts are not a mandatory test panel.

    Useful evidence: Existing protocols/results and design-specific evidence gaps, with standard editions and scope reviewed separately.

Work packages and dependencies

What needs to happen first

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[6451] · record 83cac98e4ca6d8ca65f29f4913b48b3b84874a3152b27707dd96a94ea52a604e
  • [4] Complete results array / fda-decision-context:K120743 · record whole dataset partition

FDA 510(k) summary — K120743 ↗

Mon, 23 Apr 2012 04:35:13 GMT · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot 3cebdf3b1d3993b665f6fe7bffaeae8d8aad2e3ac93338597fb164df19ef4211

  • [2] PDF page 1 · record 45a5abc5fb5321e0c526e7c3c76a75fbb2223315a396e7de287aaf034a893448
  • [3] PDF page 2 · record adc674b2019788aca04df352605326388175d6bc4bb951648122206366fff12f

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services

Biocompatibility Testing (ISO 10993 Program)